Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China · Delayed Price · Currency is CNY 21.23
-0.80 (-3.63%)
At close: Sep 10, 2026
Enwei Pharmaceutical Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 826.13 | 900.77 | 812.13 | 785.19 | 691.57 | 679.7 |
Revenue Growth | -5.39% | 10.91% | 3.43% | 13.54% | 1.75% | 7.18% |
Gross Profit Gross Profit Growth | 417 | 447.41 | 407.96 | 400.83 | 345.37 | 381.03 |
Operating Income Operating Income Growth | 29.02 | 59 | 41.98 | 80.38 | 68.31 | 99.69 |
Net Income Net Income Growth | 29.62 | 51.94 | 37.5 | 86.31 | 67.8 | 101.73 |
Earnings Per Share EPS Growth | 0.28 | 0.50 | 0.37 | 0.84 | 0.80 | 1.31 |
EPS Growth | -51.12% | 35.73% | -55.75% | 4.40% | -38.49% | -3.27% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 896.64 | 808.19 | - | - | - |
Others Others Growth | 4.14 | 3.94 | 158.24 | 116.99 | 91.98 |
Total Total Growth | 900.77 | 812.13 | 785.19 | 691.57 | 679.7 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 474.82 | 533.58 | 515 | 393.28 | 578.14 | 78.65 |
Total Debt Total Debt Growth | 202.79 | 188.04 | 197.88 | 1.34 | - | - |
Net Cash (Debt) Net Cash Growth | 272.02 | 345.54 | 317.12 | 391.94 | 578.14 | 78.65 |
Net Cash Growth | -20.66% | 8.96% | -19.09% | -32.21% | 635.07% | 1.59% |
Net Cash Per Share Net Cash Per Share Growth | 2.60 | 3.35 | 3.14 | 3.81 | 6.85 | 1.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 100.48 | 109.59 | 78.92 | 84.01 | 62.35 | 87.58 |
Capital Expenditures CapEx Growth | -49.82 | -56.38 | -50.23 | -134.05 | -23.56 | -38.21 |
Free Cash Flow Free Cash Flow Growth | 50.66 | 53.21 | 28.69 | -50.04 | 38.8 | 49.36 |
Free Cash Flow Growth | 459.50% | 85.50% | - | - | -21.41% | 4.24% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 50.48% | 49.67% | 50.23% | 51.05% | 49.94% | 56.06% |
Operating Margin | 3.51% | 6.55% | 5.17% | 10.24% | 9.88% | 14.67% |
Pretax Margin | 4.40% | 7.12% | 5.75% | 12.90% | 11.84% | 17.53% |
Profit Margin | 3.59% | 5.77% | 4.62% | 10.99% | 9.80% | 14.97% |
FCF Margin | 6.13% | 5.91% | 3.53% | -6.37% | 5.61% | 7.26% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.660 | 0.680 | 0.180 | 0.540 | 1.600 |
Dividend Per Share Growth | 472.22% | 277.78% | -66.70% | -66.22% | - |
Dividend Yield | 3.02% | 2.67% | 0.81% | 2.05% | 6.59% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 74.97 | 51.45 | 61.53 | 33.73 | 41.13 | - |
P/FCF Ratio | 42.69 | 50.22 | 80.43 | - | 71.88 | - |
PS Ratio | 2.62 | 2.97 | 2.84 | 3.71 | 4.03 | - |